AIM: To report outcomes on patients undergoing radiofrequency ablation (RFA) for early
oesophageal squamous neoplasia from a National Registry. METHODS: A Prospective …

BACKGROUND: Radiofrequency ablation (RFA) is safe and effective for eradicating
neoplasia in Barrett's esophagus. OBJECTIVE: To evaluate RFA for eradicating early …

Background and Aims Radiofrequency ablation (RFA) is an accepted treatment for flat
Barrett's neoplasia. Less is known about RFA for esophageal squamous cell neoplasia …

Background and study aims: Endoscopic radiofrequency ablation (RFA) is an established
therapy for Barrett's esophagus. Preliminary reports, limited by low patient numbers, also …

Esophageal squamous cell carcinoma comprises the majority of esophageal carcinoma in
the Eastern Asia. The need of early detection of precancerous neoplastic lesions and cancer …

BACKGROUND The progression of Barrett's esophagus (BE) to early esophageal
carcinoma occurs sequentially; the metaplastic epithelium develops from a low-grade …

Esophageal cancer is the sixth most common cause of cancer death in the world [1]. Over
80% of esophageal cancers occur in developing countries [1], and in these areas, 90% of …

Background Endoscopic radiofrequency ablation (RFA) is a treatment option for early
esophageal squamous cell neoplasia (ESCN); however, long-term follow-up studies are …

Endoscopic resection (EMR) and radiofrequency ablation (RFA) form part of the treatment of
Barrett's oesophagus (BO), dysplasia, superficial adenocarcinoma (OAC) associated with …

BACKGROUND & AIMS: Patients with Barrett's esophagus (BE) and high-grade dysplasia
(HGD) or early neoplasia increasingly receive endoscopic mucosal resection and …